MeVis Medical Solutions AG (M3V.DE)
EUR 24.6
(0.0%)
EUR 24.6
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 7 Million EUR | -6.21% |
| 2022 | 18.01 Million EUR | 14.19% |
| 2021 | 15.77 Million EUR | -4.41% |
| 2020 | 16.5 Million EUR | -6.31% |
| 2019 | 17.61 Million EUR | 8.18% |
| 2018 | 16.28 Million EUR | -9.7% |
| 2017 | 18.03 Million EUR | 80.92% |
| 2016 | 9.96 Million EUR | -35.28% |
| 2015 | 15.4 Million EUR | 23.64% |
| 2014 | 12.45 Million EUR | -10.6% |
| 2013 | 13.93 Million EUR | 8.76% |
| 2012 | 12.81 Million EUR | -1.19% |
| 2011 | 12.96 Million EUR | -9.27% |
| 2010 | 14.29 Million EUR | 6.57% |
| 2009 | 13.41 Million EUR | 27.99% |
| 2008 | 10.47 Million EUR | 44.67% |
| 2007 | 7.24 Million EUR | -8.5% |
| 2006 | 7.91 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.72 Million EUR | 0.0% |
| 2024 Q1 | 1.72 Million EUR | -0.78% |
| 2023 Q1 | 1.76 Million EUR | -23.53% |
| 2023 FY | 16.89 Million EUR | -6.21% |
| 2023 Q4 | 1.73 Million EUR | 0.0% |
| 2023 Q3 | 1.73 Million EUR | -1.33% |
| 2023 Q2 | 1.76 Million EUR | 0.0% |
| 2022 Q3 | 2.3 Million EUR | -41.41% |
| 2022 FY | 18.01 Million EUR | 14.19% |
| 2022 Q4 | 2.3 Million EUR | 0.0% |
| 2022 Q1 | 1.99 Million EUR | -38.34% |
| 2022 Q2 | 3.93 Million EUR | 97.5% |
| 2021 Q1 | 1.81 Million EUR | -53.04% |
| 2021 FY | 15.77 Million EUR | -4.41% |
| 2021 Q4 | 3.23 Million EUR | 96.25% |
| 2021 Q3 | 1.64 Million EUR | -53.86% |
| 2021 Q2 | 3.56 Million EUR | 96.49% |
| 2020 FY | 16.5 Million EUR | -6.31% |
| 2020 Q1 | 2 Million EUR | -62.43% |
| 2020 Q2 | 3.91 Million EUR | 95.33% |
| 2020 Q3 | 1.97 Million EUR | -49.72% |
| 2020 Q4 | 3.86 Million EUR | 96.25% |
| 2019 Q4 | 5.33 Million EUR | 25.04% |
| 2019 FY | 17.61 Million EUR | 8.18% |
| 2019 Q3 | 4.27 Million EUR | 9.85% |
| 2019 Q2 | 3.88 Million EUR | -5.66% |
| 2019 Q1 | 4.12 Million EUR | -7.75% |
| 2018 Q3 | 3.78 Million EUR | -1.12% |
| 2018 Q2 | 3.82 Million EUR | -9.1% |
| 2018 Q1 | 4.2 Million EUR | -1.57% |
| 2018 FY | 16.28 Million EUR | -9.7% |
| 2018 Q4 | 4.46 Million EUR | 18.05% |
| 2017 Q1 | 5.33 Million EUR | 123.91% |
| 2017 Q3 | 4.35 Million EUR | 7.29% |
| 2017 Q4 | 4.27 Million EUR | -1.88% |
| 2017 Q2 | 4.06 Million EUR | -23.9% |
| 2017 FY | 18.03 Million EUR | 80.92% |
| 2016 Q4 | 2.38 Million EUR | -35.22% |
| 2016 Q1 | 3.8 Million EUR | -18.16% |
| 2016 FY | 9.96 Million EUR | -35.28% |
| 2016 Q3 | 3.68 Million EUR | -2.44% |
| 2016 Q2 | 3.77 Million EUR | -0.97% |
| 2015 FY | 15.4 Million EUR | 23.64% |
| 2015 Q4 | 4.65 Million EUR | 28.49% |
| 2015 Q3 | 3.62 Million EUR | 9.2% |
| 2015 Q2 | 3.31 Million EUR | 0.94% |
| 2015 Q1 | 3.28 Million EUR | -4.84% |
| 2014 Q4 | 3.45 Million EUR | 14.11% |
| 2014 Q3 | 3.02 Million EUR | 12.41% |
| 2014 Q2 | 2.69 Million EUR | -20.59% |
| 2014 Q1 | 3.39 Million EUR | -16.3% |
| 2014 FY | 12.45 Million EUR | -10.6% |
| 2013 Q2 | 3.23 Million EUR | 6.35% |
| 2013 Q1 | 3.04 Million EUR | -0.88% |
| 2013 FY | 13.93 Million EUR | 8.76% |
| 2013 Q3 | 3.26 Million EUR | 0.87% |
| 2013 Q4 | 4.05 Million EUR | 24.2% |
| 2012 Q3 | 3.12 Million EUR | -12.52% |
| 2012 Q4 | 3.06 Million EUR | -1.82% |
| 2012 Q2 | 3.57 Million EUR | 16.13% |
| 2012 FY | 12.81 Million EUR | -1.19% |
| 2012 Q1 | 3.07 Million EUR | -7.13% |
| 2011 Q3 | 2.9 Million EUR | -20.85% |
| 2011 Q1 | 3.38 Million EUR | -2.0% |
| 2011 FY | 12.96 Million EUR | -9.27% |
| 2011 Q2 | 3.67 Million EUR | 8.41% |
| 2011 Q4 | 3.31 Million EUR | 13.9% |
| 2010 Q1 | 3.57 Million EUR | -5.13% |
| 2010 Q2 | 4.11 Million EUR | 15.23% |
| 2010 Q3 | 3.42 Million EUR | -16.67% |
| 2010 FY | 14.29 Million EUR | 6.57% |
| 2010 Q4 | 3.45 Million EUR | 0.82% |
| 2009 Q4 | 3.76 Million EUR | 38.23% |
| 2009 Q2 | 4.08 Million EUR | 0.0% |
| 2009 FY | 13.41 Million EUR | 27.99% |
| 2009 Q3 | 2.72 Million EUR | -33.39% |
| 2008 Q3 | 3.05 Million EUR | 0.0% |
| 2008 FY | 10.47 Million EUR | 44.67% |
| 2007 FY | 7.24 Million EUR | -8.5% |
| 2006 FY | 7.91 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| DocCheck AG | 12.97 Million EUR | 46.025% |
| CompuGroup Medical SE & Co. KGaA | 374.5 Million EUR | 98.13% |
| Nexus AG | 65.97 Million EUR | 89.386% |